BURLINGTON, Mass., June 17, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) is set to join the Russell 2000 (R) and the Russell 3000 (R) Indexes at the conclusion of the Russell indexes annual reconstitution on June 26, according to a preliminary list of additions posted June 12.
Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Membership in the small-cap Russell 2000, which remains in place for one year, is automatic based on the Company’s inclusion in the Russell 3000. The Company will also be included in the appropriate growth and value style index. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
George W. LeMaitre, Chairman and CEO, commented, “We are very pleased to be included in the Russell 2000 this year, as it is reflective of our continued growth and raises our visibility within the investment community."
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $5.7 trillion in assets are benchmarked to the Russell’s U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
For more information on the Russell 2000 and the Russell reconstitution, go to the “ Recon Central ” section on the FTSE Russell website.
About LeMaitre Vascular LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com .
About FTSE Russell FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 80 countries, covering 98% of the investable market globally and trading on over 25 exchanges worldwide.
FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit www.ftserussell.com .
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding the Company’s business that are not historical facts may be “forward-looking statements” that involve risks and uncertainties. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted. These risks and uncertainties include, but are not limited to, the risk that the Company may not achieve inclusion in the indexes and other risks and uncertainties included under the heading “Risk Factors” in its most recent Annual Report on Form 10-K, as updated by its subsequent filings with the SEC, all of which are available on the Company’s investor relations website at http://www.lemaitre.com and on the SEC’s website at http://www.sec.gov . Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
LeMaitre Vascular, Inc. Beth Kurth +1-781-425-1659 bkurth@lemaitre.com http://www.lemaitre.com
